In a recent interview with Contemporary Pediatrics, Aldo A. Conti, PhD, MsC, BsC, CPsychol, research associate at King’s College London, discussed findings from a large, multicenter clinical trial evaluating the safety and efficacy of trigeminal nerve stimulation (TNS), a noninvasive brain stimulation device marketed for children and adolescents with attention-deficit/hyperactivity disorder (ADHD).